Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.24 USD | +8.04% | +11.49% | +87.81% |
May. 09 | Earnings Flash (LPCN) LIPOCINE Reports Q1 Revenue $7.6M | MT |
May. 01 | Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+87.81% | 25.94M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- LPCN Stock
- News Lipocine Inc.
- Lipocine : HC Wainwright Adjusts Price Target for Lipocine to $2.50 From $3, Maintains Buy Rating